Trial record 10 of 121 for:
Brain and Spinal Tumors
Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Brain, Head and Neck, and Spine Cancer
This study is currently recruiting participants.
Verified April 2013 by Memorial Sloan-Kettering Cancer Center
Sponsor:
Memorial Sloan-Kettering Cancer Center
Information provided by (Responsible Party):
Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:
NCT01535898
First received: February 13, 2012
Last updated: April 2, 2013
Last verified: April 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Magnetic resonance imaging (MRI) is a diagnostic study that makes pictures of organs of the body using magnetic field and radio frequency pulses that can not be felt. The purpose of this study is to determine if a new MR imaging method can help tumor evaluation in head and neck cancer or spine metastases or primary or secondary brain tumors. The extra images will be obtained using Diffusion-weighted Magnetic Resonance Imaging which provides image contrast through detection of small restrictions in the movement of water molecules. This study may help us provide additional information about the tumor along with the picture of the organ.
| Condition | Intervention |
|---|---|
|
Head and Neck Cancer Spine Metastases Primary Brain Tumors Secondary Brain Tumors |
Other: MRI scanner with sequence |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Brain, Head and Neck, and Spine Cancer |
Resource links provided by NLM:
Further study details as provided by Memorial Sloan-Kettering Cancer Center:
Primary Outcome Measures:
- feasibility of high resolution diffusion-weighted imaging [ Time Frame: 2 years ] [ Designated as safety issue: No ]using a new DWI pulse sequence from the manufacturer (General Electric Medical Systems (Milwaukee, WI)) for the assessment of head and neck cancer cancer, spine metastases or primary or secondary brain tumors.
| Estimated Enrollment: | 30 |
| Study Start Date: | February 2012 |
| Estimated Study Completion Date: | February 2014 |
| Estimated Primary Completion Date: | February 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Pts having an MRI
This is a technology assessment protocol. The study is designed to assess the utility of the technology using a limited number of participants.
|
Other: MRI scanner with sequence
The intervention for the patients is the additional 10 minutes in the MRI scanner with sequence. The intervention for the volunteers is the scan, which will take a total of 30 minutes. The volunteers will have two more additional studies at 1-2 week intervals. Both the patients and volunteers will also need to fill out a questionnaire.
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Adults aged 18 and over.
- Men and women without regard to ethnic background.
- Patients/Subjects able to give informed consent
- Patients/Subjects whose weight does not exceed 275 lbs.
- Patient with a known or suspected head and neck cancer spine metastases or primary or secondary brain tumors scheduled for an MRI scan as part of their routine care --OR--
- Volunteer with no history of the disease in that category.
Exclusion Criteria:
- Patients who are unwilling or unable to undergo MRI including patients with contra-indications to MRI such as the presence of cardiac pacemakers or non-compatible intracranial vascular clips.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01535898
Contacts
| Contact: Amita Dave, PhD | 212-639-3184 | |
| Contact: Yonggang Lu, PhD | 212-639-7036 |
Locations
| United States, New York | |
| Memorial Sloan-Kettering Cancer Center 1275 York Avenue | Recruiting |
| New York, New York, United States, 10021 | |
| Contact: Amita Dave, PhD 212-639-3184 | |
| Contact: Yonggang Lu, PhD 212-639-7036 | |
| Principal Investigator: Amita Dave, PhD | |
Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
Investigators
| Principal Investigator: | Amita Dave, PhD | Memorial Sloan-Kettering Cancer Center |
More Information
Additional Information:
No publications provided
| Responsible Party: | Memorial Sloan-Kettering Cancer Center |
| ClinicalTrials.gov Identifier: | NCT01535898 History of Changes |
| Other Study ID Numbers: | 12-033 |
| Study First Received: | February 13, 2012 |
| Last Updated: | April 2, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Memorial Sloan-Kettering Cancer Center:
|
MRI MR imaging Pulse Sequence High Resolution Diffusion-weighted Questionnaire 12-033 |
Additional relevant MeSH terms:
|
Brain Neoplasms Head and Neck Neoplasms Neoplasm Metastasis Spinal Cord Neoplasms Central Nervous System Neoplasms Nervous System Neoplasms Neoplasms by Site Neoplasms |
Brain Diseases Spinal Cord Diseases Body Weight Signs and Symptoms Central Nervous System Diseases Nervous System Diseases Neoplastic Processes Pathologic Processes |
ClinicalTrials.gov processed this record on June 17, 2013